LabCompass

Dana K. Mitchell

Medicine · Indiana University

OpenAlex ORCID
Neurofibromatosis and Schwannoma CasesNeuroblastoma Research and TreatmentsMeningioma and schwannoma managementNerve injury and regenerationAcute Myeloid Leukemia Research

Publications

353

Citations

406

Est. group size

~1

Recurring co-author estimate

Active years

9

Publishing since 2018

Research summary
AI-generated

Dana K. Mitchell conducts medical research focused on tumors of the nervous system, including nerve-sheath tumors such as schwannomas linked to a genetic condition called NF2-related schwannomatosis, as well as brain tumors like glioblastoma. The work spans studying tumor biology, testing drug targets, and exploring immune-based and molecular treatment strategies. Some studies also examine how blocking specific enzymes can slow tumor growth while preserving healthy function, such as hearing.

Nerve-sheath tumors (schwannoma/neurofibromatosis)Brain tumor biology and treatmentCancer immunotherapyMolecular drug targets and enzyme inhibitionNeuro-oncology

Publication activity was low through 2022 and then rose sharply from 2023 onward, indicating a strongly growing output in recent years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 68.6/year recently
172018: 1 publication182019: 3 publications192020: 2 publications202021: 4 publications212022: 2 publications222023: 84 publications232024: 136 publications136242025: 86 publications252026: 35 publications26
Recent publications
Publishes in
  • Figshare×14
  • Clinical Cancer Research×4
  • Frontiers in Oncology×3
  • Proceedings of IMPRS×3
  • UNC Libraries×3

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile